Shirley J. Lasch
-
- Monoclonal and Polyclonal Antibodies Research 5
- Radiopharmaceutical Chemistry and Applications 2
- Oncology top 5%
- Peptidase Inhibition and Analysis 8
- HER2/EGFR in Cancer Research 2
- Biomaterials top 5%
- Nanoparticle-Based Drug Delivery 1
-
- Glycosylation and Glycoproteins Research 2
- Biotechnology top 10%
- Cancer Research and Treatments 2
-
- Click Chemistry and Applications 2
- Co-authors
- Pamela A. TrailDavid WillnerRaymond A. FirestoneSandra J. HofsteadGene M. DubowchikArris J. HendersonIngegerd HellströmDalton King
- Journals
- Science (1 paper)Journal of Controlled Release (1 paper)Journal of Medicinal Chemistry (1 paper)
- Partner nations
- United StatesGermanySwitzerland
In The Last Decade
Shirley J. Lasch
11 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 72
- Radiology, Nuclear Medicine and Imaging 722
- Oncology 680
- Biomaterials 211
- Molecular Biology 600
- Biotechnology 69
Countries citing papers authored by Shirley J. Lasch
This map shows the geographic impact of Shirley J. Lasch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shirley J. Lasch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shirley J. Lasch more than expected).
Fields of papers citing papers by Shirley J. Lasch
This network shows the impact of papers produced by Shirley J. Lasch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shirley J. Lasch. The network helps show where Shirley J. Lasch may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Shirley J. Lasch, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2003 | 16 | |
| 2 | 2002 | 30 | |
| 3 | 2002 | 100 | |
| 4 | 2002 | 396 | |
| 5 | Enhanced antitumor activity of paclitaxel in combination with the anticarcinoma immunoconjugate BR96-doxorubicin. | 1999 | 32 |
| 6 | 1999 | 60 | |
| 7 | Effect of linker variation on the stability, potency, and efficacy of carcinoma-reactive BR64-doxorubicin immunoconjugates. | 1997 | 45 |
| 8 | 1996 | 27 | |
| 9 | 1993 | 414 | |
| 10 | 1993 | 183 | |
| 11 | Antigen-specific activity of carcinoma-reactive BR64-doxorubicin conjugates evaluated in vitro and in human tumor xenograft models. | 1992 | 50 |
About Shirley J. Lasch
Shirley J. Lasch is a scholar working on Oncology, Biotechnology and Radiology, Nuclear Medicine and Imaging, having authored 11 papers that have together received 1.4k indexed citations. Recurring topics across this work include Peptidase Inhibition and Analysis (8 papers), Monoclonal and Polyclonal Antibodies Research (5 papers), Glycosylation and Glycoproteins Research (2 papers), Click Chemistry and Applications (2 papers), Cancer Research and Treatments (2 papers), Radiopharmaceutical Chemistry and Applications (2 papers), HER2/EGFR in Cancer Research (2 papers) and Nanoparticle-Based Drug Delivery (1 paper). The work is most often cited by research in Radiology, Nuclear Medicine and Imaging (722 citations), Oncology (680 citations) and Biomaterials (211 citations). Shirley J. Lasch has collaborated with scholars based in United States, Germany and Switzerland. Frequent co-authors include Pamela A. Trail, David Willner, Raymond A. Firestone, Sandra J. Hofstead, Gene M. Dubowchik, Arris J. Henderson, Ingegerd Hellström, Dalton King, Anna Maria Casazza and K E Hellström. Their work appears in journals such as Science, Journal of Controlled Release and Journal of Medicinal Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.